A Phase Ib, Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Orally Administered DF-003 in ROSAH Syndrome Patients
Clinical Trial Grant
Administered By
Ophthalmology, Vitreoretinal Diseases & Surgery
Awarded By
Shanghai Yao Yuan Biotechnology, Ltd _ AKA Drug Farm
Start Date
January 29, 2025
End Date
January 31, 2030
Administered By
Ophthalmology, Vitreoretinal Diseases & Surgery
Awarded By
Shanghai Yao Yuan Biotechnology, Ltd _ AKA Drug Farm
Start Date
January 29, 2025
End Date
January 31, 2030